Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2012-01-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/annrheumdis-2011-200493PMID 22267330PMCID PMC3428121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis

  2010cited by this paper
• Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.

  2010cited by this paper
• Infliximab Reduces Myeloperoxidase Concentration in Chronic Inflammatory Joint Diseases

  2009cited by this paper
• Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis.

  2009cited by this paper
• The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis This work was supported by P01-HL22633 from the NHLBI. Published, JLR Papers in Press, December 8, 2008.

  2009cited by this paper
• Inflammation Impairs Reverse Cholesterol Transport In Vivo

  2009cited by this paper
• Corrigendum: The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction

  2008cited by this paper
• Redox signalling and the inflammatory response in rheumatoid arthritis

  2008cited by this paper
• Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I

  2008cited by this paper
• Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients

  2008cited by this paper
• Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis.

  2007cited by this paper
• Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study.

  2007cited by this paper
• The widening mortality gap between rheumatoid arthritis patients and the general population.

  2007cited by this paper
• Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?

  2006cited by this paper
• Myeloperoxidase Impairs ABCA1-dependent Cholesterol Efflux through Methionine Oxidation and Site-specific Tyrosine Chlorination of Apolipoprotein A-I*

  2006cited by this paper
• Cardiovascular death in rheumatoid arthritis: a population-based study.

  2005cited by this paper
• Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

  2005cited by this paper
• Localization of Nitration and Chlorination Sites on Apolipoprotein A-I Catalyzed by Myeloperoxidase in Human Atheroma and Associated Oxidative Impairment in ABCA1-dependent Cholesterol Efflux from Macrophages*

  2005cited by this paper
• The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.

  2004cited by this paper
• Oral D-4F Causes Formation of Pre-βHigh-Density Lipoprotein and Improves High-Density Lipoprotein–Mediated Cholesterol Efflux and Reverse Cholesterol Transport From Macrophages in Apolipoprotein E–Null Mice

  2004cited by this paper
• Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

  2004cited by this paper
• Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis.

  2003cited by this paper
• Prognostic value of myeloperoxidase in patients with chest pain.

  2003cited by this paper
• Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects.

  2003cited by this paper
• Regulation of reverse cholesterol transport and clinical implications.

  2003cited by this paper
• Treating rheumatoid arthritis early: a window of opportunity?

  2002cited by this paper
• High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.

  2001cited by this paper
• A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids.

  2001cited by this paper
• Myeloperoxidase-generated oxidants and atherosclerosis.

  2000cited by this paper
• Human neutrophils employ chlorine gas as an oxidant during phagocytosis.

  1996cited by this paper
• Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon.

  1988cited by this paper

• Pathogenic Drivers of Difficult-to-Treat Rheumatoid Arthritis: Synovium and Beyond.

  2026cites this paper
• Aberrant Nutrient Metabolism in T Cells: Pathogenesis Insight and Therapeutic Target for Autoimmune Diseases

  2025cites this paper
• Modifications on lipid profile and high-density lipoprotein function related to treatment with tofacitinib in female patients with rheumatoid arthritis: Impact of previous therapy with biological agents.

  2025cites this paper
• Post-Translational Modifications of Lipoproteins: Emerging Players Linking Inflammation and Cardiovascular Disease in Rheumatoid Arthritis—A Narrative Review

  2025cites this paper
• High-density lipoproteins. Part 2. Impact of disease states on functionality

  2025cites this paper
• Lipid metabolism in myeloid cell function and chronic inflammatory diseases

  2025cites this paper
• Development and Validation of a Cost-Effective Machine Learning Model for Screening Potential Rheumatoid Arthritis in Primary Healthcare Clinics

  2025cites this paper
• HDL regulates the risk of cardiometabolic and inflammatory-related diseases: Focusing on cholesterol efflux capacity.

  2024cites this paper
• Cardiometabolic Risk Assessment in Transgender Individuals—Differential Effect of Sex Hormones and Sex Chromosomes

  2024cites this paper
• Treating Cardiovascular Disease in the Inflammatory Setting of Rheumatoid Arthritis: An Ongoing Challenge

  2024cites this paper
• Exploring Cardiovascular Risk Factors and Atherosclerosis in Rheumatoid Arthritis.

  2024cites this paper
• The Association Between Adverse Cardiovascular Outcomes in Celiac Disease and the Role of Inflammation: Retrospective Analysis Using the National Inpatient Sample.

  2024cites this paper
• Knockout of integrin αvβ6 protects against renal inflammation in chronic kidney disease by reduction of pro-inflammatory macrophages

  2024cites this paper
• The Composition of the HDL Particle and Its Capacity to Remove Cellular Cholesterol Are Associated with a Reduced Risk of Developing Active Inflammatory Rheumatoid Arthritis

  2024cites this paper
• Biochemical effects of simvastatin on autoimmune arthritis in a mouse induced model

  2024cites this paper
• Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: a 12 years follow up explorative study.

  2023cites this paper
• Anti‐Inflammatory Effect of High‐Density Lipoprotein Blunted by Delivery of Altered MicroRNA Cargo in Patients With Rheumatoid Arthritis

  2023cites this paper
• Dyslipidemia in rheumatoid arthritis: the possible mechanisms

  2023cites this paper
• HDL Functions—Current Status and Future Perspectives

  2023cites this paper
• Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy

  2023cites this paper
• Power doppler ultrasound signal predicts abnormal HDL function in patients with rheumatoid arthritis

  2023cites this paper
• Dysfunctional antioxidant capacity of high‐density lipoprotein in rheumatoid arthritis

  2023cites this paper
• Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis

  2023cites this paper
• Pathogenesis of Extraarticular Manifestations in Rheumatoid Arthritis—A Comprehensive Review

  2023cites this paper
• The Involvement of Glucose and Lipid Metabolism Alteration in Rheumatoid Arthritis and Its Clinical Implication

  2023cites this paper
• Impact of immune regulation and differentiation dysfunction of mesenchymal stem cells on the disease process in ankylosing spondylitis and prospective analysis of stem cell transplantation therapy.

  2023cites this paper
• Paradoxical Effects of Prolonged Insufficient Sleep on Lipid Profile: A Pooled Analysis of 2 Randomized Trials

  2023cites this paper
• Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment of Rheumatoid Arthritis: Current Perspectives

  2023cites this paper
• Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications

  2022cites this paper
• Association between Paraoxonase/Arylesterase Activity of Serum PON-1 Enzyme and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

  2022cites this paper
• Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies

  2022cites this paper
• Cardiovascular Manifestations in Rheumatoid Arthritis

  2022cites this paper
• DYSLIPIDEMIA IN PATIENTS WITH RHEUMATOID ARTHRITIS DEPENDS ON COMORBID PATHOLOGY AND GENETIC PREDICTORS

  2022cites this paper
• Does propolis have any effect on rheumatoid arthritis? A review study

  2022cites this paper
• Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis

  2022influential citation
• Alteration in serum oxidative stress balance in patients with different circulating high-density lipoprotein cholesterol levels.

  2022cites this paper
• Systemic consequences of abnormal cholesterol handling: Interdependent pathways of inflammation and dyslipidemia

  2022influential citation
• Redox regulation of the immune response

  2022cites this paper
• Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis

  2022cites this paper
• High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives

  2021cites this paper
• Ischemic Heart Disease and Rheumatoid Arthritis—Two Conditions, the Same Background

  2021cites this paper
• A hypolipoprotein sepsis phenotype indicates reduced lipoprotein antioxidant capacity, increased endothelial dysfunction and organ failure, and worse clinical outcomes

  2021cites this paper
• The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders.

  2021cites this paper
• HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases

  2021cites this paper
• Abdominal obesity negatively influences key metrics of reverse cholesterol transport.

  2021cites this paper
• The role of high‐density lipoprotein in the regulation of the immune response: implications for atherosclerosis and autoimmunity

  2021cites this paper
• Lipid Metabolism Profiles in Rheumatic Diseases

  2021cites this paper
• Improvements in High-Density Lipoprotein Quantity and Quality Contribute to the Cardiovascular Benefits by Anti-tumor Necrosis Factor Therapies in Rheumatoid Arthritis: A Systemic Review and Meta-Analysis

  2021cites this paper
• Biologics and atherosclerotic cardiovascular risk in rheumatoid arthritis: a review of evidence and mechanistic insights

  2021cites this paper
• Treatment of Cardiovascular Disease in Rheumatoid Arthritis: A Complex Challenge with Increased Atherosclerotic Risk

  2021cites this paper
• Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis

  2020influential citation
• A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with rheumatoid arthritis

  2020cites this paper
• ФАКТОРЫ РАЗВИТИЯ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ / FACTORS OF DEVELOPMENT OF CARDIOVASCULAR DISEASES

  2020cites this paper
• Lipid management in rheumatoid arthritis: a position paper by the Cardiovascular Pharmacotherapy Working Group of European Society of Cardiology.

  2020cites this paper
• High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases.

  2020cites this paper
• On the Chameleonic Behaviour of Cholesterol through a Fractal/Multifractal Model

  2020cites this paper
• HDL cholesterol efflux capacity is related to disease activity in psoriatic arthritis patients

  2020cites this paper
• Skeletal muscle disease in rheumatoid arthritis: the center of cardiometabolic comorbidities?

  2020cites this paper
• High density lipoprotein functionality and cardiovascular events and mortality: A systematic review and meta-analysis.

  2020cites this paper
• Carotid plaques in adult rheumatoid arthritis patients; association with paroxonase 1 enzymatic activity and Q192R paroxonase 1 gene polymorphism

  2020cites this paper
• The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk

  2020cites this paper
• Autoimmune rheumatic diseases and premature atherosclerotic cardiovascular disease: An analysis from the VITAL (Veterans wIth premaTure AtheroscLerosis) registry.

  2020cites this paper
• Differences in Capacity of High‐Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis

  2020cites this paper
• High- density lipoprotein function is abnormal in idiopathic inflammatory myopathies.

  2020cites this paper
• Suppression of inflammatory arthritis in human serum paraoxonase 1 transgenic mice

  2020cites this paper
• RHEUMATOID ARTHRITIS AND CARDIOVASCULAR DISEASES

  2020cites this paper
• Endothelial Dysfunction and Extra-Articular Neurological Manifestations in Rheumatoid Arthritis

  2020cites this paper
• Impaired cholesterol efflux capacity in patients with Helicobacter pylori infection and its relation with inflammation.

  2020cites this paper
• The Lipid Paradox as a Metabolic Checkpoint and Its Therapeutic Significance in Ameliorating the Associated Cardiovascular Risks in Rheumatoid Arthritis Patients

  2020cites this paper
• Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation

  2020cites this paper
• The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients

  2020cites this paper
• Management of Cardiovascular Disease Risk in Rheumatoid Arthritis

  2019cites this paper
• Accelerated Atherosclerosis in Rheumatoid Arthritis: Mechanisms and Treatment.

  2019cites this paper
• LDL and HDL lipoprotein subtype frequency in patients with rheumatoid arthritis before and after administration of anti–TNFα

  2019cites this paper
• Role and predictive value of the hdl function for cardiovascular disease in a high risk population. Hdl function-linked markers and mechanisms

  2019cites this paper
• Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis

  2019cites this paper
• Rheumatoid arthritis (RA) and cardiovascular disease.

  2019cites this paper
• Dysfunctional HDL as a Therapeutic Target for Atherosclerosis Prevention.

  2019cites this paper
• Q192R PARAOXONASE 1 GENE POLYMORPHISM AMONG RHEUMATOID ARTHRITIS PATIENTS IN ZAGAZIG UNIVERSITY HOSPITALS

  2019influential citation
• Effect of IL-6 Receptor Blockade on Proprotein Convertase Subtilisin/Kexin Type-9 and Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients

  2019cites this paper
• Allergic rhinitis is associated with complex alterations in high-density lipoprotein composition and function.

  2019cites this paper
• Cardiovascular Disease in Spondyloarthritides

  2019cites this paper
• Cardiovascular risk of synthetic, non-biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs).

  2019cites this paper
• Humoral immunity against HDL particle: a new perspective in cardiovascular diseases?

  2019cites this paper
• Immunotherapy for the rheumatoid arthritis-associated coronary artery disease: promise and future

  2019cites this paper
• Biological Consequences of Dysfunctional HDL.

  2019cites this paper
• Lipid profile and risks of cardiovascular diseases in conditions of rheumatoid arthritis.

  2019cites this paper
• Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease

  2018cites this paper
• Cardiovascular risk factors in patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs.

  2018cites this paper
• High-Density Lipoprotein Functionality as a New Pharmacological Target on Cardiovascular Disease: Unifying Mechanism That Explains High-Density Lipoprotein Protection Toward the Progression of Atherosclerosis

  2018cites this paper
• Regulation of low-density lipoprotein cholesterol by intestinal inflammation and the acute phase response.

  2018cites this paper
• Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis

  2018cites this paper
• Impact of Dietary Cholesterol on the Pathophysiology of Infectious and Autoimmune Disease

  2018cites this paper
• Defective cholesterol metabolism in haematopoietic stem cells promotes monocyte-driven atherosclerosis in rheumatoid arthritis

  2018cites this paper
• Atherosclerosis in ankylosing spondylitis: clinical implications.

  2018cites this paper
• Disordered haematopoiesis and cardiovascular disease: a focus on myelopoiesis.

  2018cites this paper
• Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents

  2018cites this paper
• Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications

  2018cites this paper
• High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis

  2018cites this paper
• Cardiovascular disease in patients with rheumatoid arthritis.

  2017cites this paper